1Y Annualised Return
▼-40.33%
3Y Annualised Return
▲5.92%
5Y Annualised Return
▲18.52%
10Y Annualised Return
▲3.75%
Godavari Drugs Stock Performance
|
|
|
Godavari Drugs Company background
Founded in: 1987
Managing director: Mukund Kakani
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used antibacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for APIs, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance valueaddition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced Pyrazyamide in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of Pyrazyamide of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale topilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
Godavari Drugs Share Price Today
As of 15 Sep, 2025, Godavari Drugs share price is ₹87.8. The stock opened at ₹82.7 and had closed at ₹82.3 the previous day. During today’s trading session, Godavari Drugs share price moved between ₹82.70 and ₹91.00, with an average price for the day of ₹86.85. Over the last 52 weeks, the stock has recorded a low of ₹79.00 and a high of ₹144.00. In terms of performance, Godavari Drugs share price has declined by 6.6% over the past six months and has declined by 40.33% over the last year.
Godavari Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹53,44,124 (-17.78%)
Daily SIP of ₹25,000 would have become ₹53,44,124 in 1 year with a gain of ₹-11,55,875 (-17.78%)
Godavari Drugs Fundamental
Market Cap (in crs)
61.96
Face Value
10
Turnover (in lacs)
8.41
Key Metrics
Qtr Change %
39.06% Fall from 52W High
-7.6
Dividend yield 1yr %
0
Godavari Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
87.75
Current Price
5Day EMA
82.60
10Day EMA
83.00
12Day EMA
83.10
20Day EMA
83.60
26Day EMA
84.00
50Day EMA
85.90
100Day EMA
89.40
200Day EMA
94.60
5Day SMA
82.80
10Day SMA
83.30
20Day SMA
83.50
30Day SMA
83.80
50Day SMA
85.60
100Day SMA
90.20
150Day SMA
91.30
200Day SMA
96.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1321 Rs | 2392 Rs |
Week Rs | 2935 Rs | 5089 Rs |
Month Rs | 2563 Rs | 3562 Rs |
Resistance & Support
83.09
Pivot
Resistance
First Resistance
84.19
Second Resistance
86.09
Third Resistance
87.19
Support
First Support
81.19
Second support
80.09
Third Support
78.19
Relative Strength Index
44.49
Money Flow Index
14.54
MACD
-0.89
MACD Signal
-0.92
Average True Range
3.68
Average Directional Index
18.49
Rate of Change (21)
-4.89
Rate of Change (125)
-11.99
Godavari Drugs Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43.62 | 72.03 | 40.4 | 91.87 | 44.27 | 2.59% | -0.14% | 1.04% | -43.41% | -16.20% | 0.00% | 25.62 | 41.21 | 3.82 | |
189.35 | 62.36 | 170 | 330 | 196.20 | 5.90% | 8.63% | -22.08% | -40.22% | 69.82% | 0.00% | 15.84 | 41.21 | 1.75 | |
69.00 | 68.60 | 26.1 | 71 | 68.60 | 4.55% | 32.59% | 94.42% | 83.07% | 102.35% | 0.00% | 171.50 | 41.21 | 2.01 | |
9.95 | 60.63 | 9.1 | 14.85 | 9.85 | 1.22% | -9.30% | -9.55% | -26.41% | 11.30% | 0.00% | 0.00 | 41.21 | 0.93 | |
12.80 | 58.52 | 8.16 | 31.4 | 11.68 | 20.19% | 31.28% | -39.99% | -57.19% | -67.05% | 0.00% | 16.69 | 41.21 | 0.70 | |
Accretion Pharmaceuticals Ltd. | - | 63.35 | - | - | - | - | - | - | - | - | - | - | - | - |
Godavari Drugs Share Price FAQs
How to buy Godavari Drugs shares?
You can easily buy Godavari Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Godavari Drugs ?
The 52-week high and low of Godavari Drugs share price is ₹144 and ₹79 as of 15/9/2025.
Please be aware that Godavari Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Godavari Drugs